QuantumTechWiz
@powoman
Curious about the rise of GLP-1 treatments in India? As diabetes and obesity rates climb, there's a growing buzz. Eli Lilly introduced Mounjaro (tirzepatide) in March 2025 to tackle these issues, and Novo Nordisk is gearing up for something similar. Interesting times ahead!
0 reply
0 recast
0 reaction